Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Omics-Based Clinical Trials Market Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028

  • BIZ4952989
  • 200 Pages
  • April 2022
  • Healthcare
Download Sample    Get Discount   
 
Global Omics-Based Clinical Trials Market is valued at approximately USD 24.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4 % over the forecast period 2022-2028. Omics-Based Clinical Trials are used for the clinical analysis of patients related to genomics, metabolomics epigenomics, proteomics etc. The growing incidences of chronic diseases have led to the adoption of Omics-Based Clinical Trials across the forecast period. For Instance: According to the Centers for Disease Control and Prevention in 2021, the number of cases and deaths by chronic diseases is increasing rapidly. The diabetic cases with illness have affected 285 million people which is equivalent to about 6.4 % of the total adult population globally. Increasing investment by pharmaceutical companies pushes the market growth of omics-based clinical trials. Also, with the increasing demand for omics approaches for clinical trials, the adoption & demand for Omics-Based Clinical Trials is likely to increase the market growth during the forecast period. However, higher costs of clinical trials impede the growth of the market over the forecast period of 2022-2028.

The geographical regions considered for the global Omics-Based Clinical Trials market analysis include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of huge market share due to the increasing cases of chronic disorders, presence of key players and growing investment towards the advancement of healthcare. Whereas, Asia-Pacific is also estimated to attain a maximum growth rate during 2022-2028. Factors such as increasing R&D in clinical trials and increasing government expenditure towards the healthcare sector would create beneficial growth forecasts for the Omics-Based Clinical Trials market across Asia-Pacific region.

Major market players included in this report are:

Parexel International Corporation

Pharmaceutical Product Development (PPD)

Charles River Laboratory

ICON plc

SGS SA

Eli Lilly and Company

Pfizer Inc.

Covance Inc.

Novo Nordisk

Rebus Bio

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Phase:

Phase I

Phase II

Phase III

Phase IV

By Study Design:

Interventional Studies

Observational Studies

Expanded Access Studies

By Indication:

Oncology

Cardiology

Respiratory Diseases

Skin Diseases

CNS Diseases

Immunology

Genetic Diseases (includes the rare diseases)

Others (includes ophthalmic, ear diseases, etc)

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019,2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Omics-Based Clinical Trials Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)

1.2.1. Omics-Based Clinical Trials Market, by Region, 2020-2028(USD Billion)

1.2.2. Omics-Based Clinical Trials Market, by Phase, 2020-2028(USD Billion)

1.2.3. Omics-Based Clinical Trials Market, by Study Design, 2020-2028(USD Billion)

1.2.4. Omics-Based Clinical Trials Market, by Indication, 2020-2028(USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Omics-Based Clinical Trials Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Omics-Based Clinical Trials Market Dynamics

3.1. Omics-Based Clinical Trials Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Growing incidences of chronic diseases

3.1.1.2. Increasing investment by pharmaceutical companies

3.1.2. Market Challenges

3.1.2.1. Higher cost of clinical trials

3.1.3. Market Opportunities

3.1.3.1. Increasing demand for omics approaches for clinical trials

Chapter 4. Global Omics-Based Clinical Trials Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Omics-Based Clinical Trials Market, by Phase

6.1. Market Snapshot

6.2. Global Omics-Based Clinical Trials Market by Phase, Performance - Potential Analysis

6.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Phase, 2019-2028 (USD Billion)

6.4. Omics-Based Clinical Trials Market, Sub Segment Analysis

6.4.1. Phase I

6.4.2. Phase II

6.4.3. Phase III

6.4.4. Phase IV

Chapter 7. Global Omics-Based Clinical Trials Market, by Study Design

7.1. Market Snapshot

7.2. Global Omics-Based Clinical Trials Market by Study Design, Performance - Potential Analysis

7.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Study Design, 2019-2028 (USD Billion)

7.4. Omics-Based Clinical Trials Market, Sub Segment Analysis

7.4.1. Interventional Studies

7.4.2. Observational Studies

7.4.3. Expanded Access Studies

Chapter 8. Global Omics-Based Clinical Trials Market, by Indication

8.1. Market Snapshot

8.2. Global Omics-Based Clinical Trials Market by Indication, Performance - Potential Analysis

8.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion)

8.4. Omics-Based Clinical Trials Market, Sub Segment Analysis

8.4.1. Oncology

8.4.2. Cardiology

8.4.3. Respiratory Diseases

8.4.4. Skin Diseases

8.4.5. CNS Diseases

8.4.6. Immunology

8.4.7. Genetic Diseases (includes the rare diseases)

8.4.8. Others (includes ophthalmic, ear diseases, etc)

Chapter 9. Global Omics-Based Clinical Trials Market, Regional Analysis

9.1. Omics-Based Clinical Trials Market, Regional Market Snapshot

9.2. North America Omics-Based Clinical Trials Market

9.2.1. U.S. Omics-Based Clinical Trials Market

9.2.1.1. Phase breakdown estimates & forecasts, 2019-2028

9.2.1.2. Study Design breakdown estimates & forecasts, 2019-2028

9.2.1.3. Indication breakdown estimates & forecasts, 2019-2028

9.2.2. Canada Omics-Based Clinical Trials Market

9.3. Europe Omics-Based Clinical Trials Market Snapshot

9.3.1. U.K. Omics-Based Clinical Trials Market

9.3.2. Germany Omics-Based Clinical Trials Market

9.3.3. France Omics-Based Clinical Trials Market

9.3.4. Spain Omics-Based Clinical Trials Market

9.3.5. Italy Omics-Based Clinical Trials Market

9.3.6. Rest of Europe Omics-Based Clinical Trials Market

9.4. Asia-Pacific Omics-Based Clinical Trials Market Snapshot

9.4.1. China Omics-Based Clinical Trials Market

9.4.2. India Omics-Based Clinical Trials Market

9.4.3. Japan Omics-Based Clinical Trials Market

9.4.4. Australia Omics-Based Clinical Trials Market

9.4.5. South Korea Omics-Based Clinical Trials Market

9.4.6. Rest of Asia Pacific Omics-Based Clinical Trials Market

9.5. Latin America Omics-Based Clinical Trials Market Snapshot

9.5.1. Brazil Omics-Based Clinical Trials Market

9.5.2. Mexico Omics-Based Clinical Trials Market

9.6. Rest of The World Omics-Based Clinical Trials Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Parexel International Corporation

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Pharmaceutical Product Development (PPD)

10.2.3. Charles River Laboratory

10.2.4. ICON plc

10.2.5. SGS SA

10.2.6. Eli Lilly and Company

10.2.7. Pfizer Inc.

10.2.8. Covance Inc.

10.2.9. Novo Nordisk

10.2.10. Rebus Bio

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Omics-Based Clinical Trials market, report scope

TABLE 2. Global Omics-Based Clinical Trials market estimates & forecasts by Region 2019-2028 (USD Billion)

TABLE 3. Global Omics-Based Clinical Trials market estimates & forecasts by Phase 2019-2028 (USD Billion)

TABLE 4. Global Omics-Based Clinical Trials market estimates & forecasts by Study Design 2019-2028 (USD Billion)

TABLE 5. Global Omics-Based Clinical Trials market estimates & forecasts by Indication 2019-2028 (USD Billion)

TABLE 6. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 7. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 8. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 9. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 10. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 11. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 12. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 13. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 14. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 15. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 16. U.S. Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 17. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 18. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 19. Canada Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 20. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 21. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 22. UK Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 23. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 24. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 25. Germany Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 26. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 27. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 28. RoE Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 29. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 30. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 31. China Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 32. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 33. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 34. India Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 35. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 36. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 37. Japan Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 38. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 39. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 40. RoAPAC Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 41. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 42. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 43. Brazil Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 44. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 45. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 46. Mexico Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 47. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 48. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 49. RoLA Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 50. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 51. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 52. Row Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 53. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 54. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 55. List of secondary sources, used in the study of global Omics-Based Clinical Trials market

TABLE 56. List of primary sources, used in the study of global Omics-Based Clinical Trials market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research